Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Severe ipsilateral musculoskeletal involvement in a Cornelia de Lange patient with a novel NIPBL mutation

  • Baquero-Montoya, Carolina
  • Gil-Rodríguez, María-Concepción
  • Hernández-Marcos, María
  • Teresa-Rodrigo, María-Esperanza
  • Vicente-Gabas, Alicia
  • Bernal, María-Luisa
  • Casale, Cesar-Horacio
  • Bueno-Lozano, Gloria
  • Bueno-Martínez, Inés
  • Queralt, Ethel
  • Villa, Olaya
  • Hernando-Davalillo, Cristina
  • Armengol, Lluís
  • Gómez-Puertas, Paulino
  • Puisac, Beatriz
  • Selicorni, Angelo
  • Ramos, Feliciano J.
  • Pié, Juan
14 páginas., Cornelia de Lange Syndrome (CdLS) is a congenital autosomal dominant (NIPBL, SMC3 and RAD21) or X-linked (SMC1A and HDAC8) disorder characterized by facial dysmorphism, pre and postnatal growth retardation, developmental delay and/or intellectual disability, and multiorgan involvement. Musculoskeletal malformations are usually bilateral and affect mainly the upper limbs; the range goes from brachyclinodactyly to severe reduction defects. Instead lower extremities are usually less and mildly involved. Here, we report on a 3-year-old Senegalese boy with typical craniofacial CdLS features, pre and postnatal growth retardation, atrial septal defect, developmental delay and right ipsilateral limb malformations, consistent with oligodactyly of the 3rd and 4th fingers, tibial agenesis and fibula hypoplasia. Exome sequencing and Sanger sequencing showed a novel missense mutation in NIPBL gene (c.6647A>G; p.(Tyr2216Cys)), which affects a conserved residue located within NIPBL HEAT repeat elements. Pyrosequencing analysis of NIPBL gene, disclosed similar levels of wild-type and mutated alleles in DNA and RNA samples from all tissues analyzed (oral mucosa epithelial cells, peripheral blood leukocytes and fibroblasts). These findings indicated the absence of somatic mosaicism, despite of the segmental asymmetry of the limbs, and confirmed biallelic expression for NIPBL transcripts, respectively. Additionally, conditions like Split-hand/foot malformation with long-bone deficiency secondary to duplication of BHLHA9 gene have been ruled out by the array-CGH and MLPA analysis. To our knowledge, this is the first CdLS patient described with major ipsilateral malformations of both the upper and lower extremities, that even though this finding could be due to a random event, expands the spectrum of limb reduction defects in CdLS, This study was funded by grant from: The Spanish Ministry of Health - Fondo de Investigación Sanitaria (FIS) (Ref.#PI12/01318), the Diputación General de Aragón (Grupo Consolidado B20), European Social Fund (Construyendo Europa desde Aragón), Spanish Ministerio de Economía y Competitividad (Refs.# IPT2011-0964-900000 and # SAF2011-13156-E, to P.G-P) and Fundació la Marató de TV3 (Exp. 101030 to E.Q). M.E.T-R is the recipient of fellowships from University of Zaragoza (Ref.# PIFUZ_ 2009-BIO-02), Peer reviewed
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Identification and Functional Characterization of Two Intronic NIPBL Mutations in Two Patients with Cornelia de Lange Syndrome

  • Teresa-Rodrigo, M.
  • Eckhold, J.
  • Puisac, B.
  • Pozojevic, J.
  • Parenti, I.
  • Baquero-Montoya, C.
  • Gil-Rodríguez, M.C.
  • Braunholz, D.
  • Dalski, A.
  • Hernández-Marcos, M.
  • Ayerza, A.
  • Bernal, M.L.
  • Ramos, F.J.
  • Wieczorek, D.
  • Gillessen-Kaesbach, G.
  • Pié, J.
  • Kaiser, F.J.
Cornelia de Lange syndrome (CdLS) is a rare genetically heterogeneous disorder with a high phenotypic variability including mental retardation, developmental delay, and limb malformations. The genetic causes in about 30% of patients with CdLS are still unknown. We report on the functional characterization of two intronic NIPBL mutations in two patients with CdLS that do not affect a conserved splice-donor or acceptor site. Interestingly, mRNA analyses showed aberrantly spliced transcripts missing exon 28 or 37, suggesting the loss of the branch site by the c.5329-15A>G transition and a disruption of the polypyrimidine by the c.6344del(-13)-(-8) deletion. While the loss of exon 28 retains the reading frame of the NIBPL transcript resulting in a shortened protein, the loss of exon 37 shifts the reading frame with the consequence of a premature stop of translation. Subsequent quantitative PCR analysis demonstrated a 30% decrease of the total NIPBL mRNA levels associated with the frameshift transcript. Consistent with our results, this patient shows a more severe phenotype compared to the patient with the aberrant transcript that retains its reading frame. Thus, intronic variants identified by sequencing analysis in CdLS diagnostics should carefully be examined before excluding them as nonrelevant to disease.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Functional characterization of NIPBL physiological splice variants and eight splicing mutations in patients with cornelia de lange syndrome

  • Teresa-Rodrigo, M.
  • Eckhold, J.
  • Puisac, B.
  • Dalski, A.
  • Gil-Rodríguez, M.C.
  • Braunholz, D.
  • Baquero, C.
  • Hernández-Marcos, M.
  • de Karam, J.C.
  • Ciero, M.
  • Santos-Simarro, F.
  • Lapunzina, P.
  • Wierzba, J.
  • Casale, C.H.
  • Ramos, F.J.
  • Gillessen-Kaesbach, G.
  • Kaiser, F.J.
  • Pié, J.
Cornelia de Lange syndrome (CdLS) is a congenital developmental disorder characterized by distinctive craniofacial features, growth retardation, cognitive impairment, limb defects, hirsutism, and multisystem involvement. Mutations in five genes encoding structural components (SMC1A, SMC3, RAD21) or functionally associated factors (NIPBL, HDAC8) of the cohesin complex have been found in patients with CdLS. In about 60% of the patients, mutations in NIPBL could be identified. Interestingly, 17% of them are predicted to change normal splicing, however, detailed molecular investigations are often missing. Here, we report the first systematic study of the physiological splicing of the NIPBL gene, that would reveal the identification of four new splicing isoforms ¿E10, ¿E12, ¿E33,34, and B’. Furthermore, we have investigated nine mutations affecting splice-sites in the NIPBL gene identified in twelve CdLS patients. All mutations have been examined on the DNA and RNA level, as well as by in silico analyses. Although patients with mutations affecting NIPBL splicing show a broad clinical variability, the more severe phenotypes seem to be associated with aberrant transcripts resulting in a shift of the reading frame.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Reseña (Review)

Diagnosis and management of Cornelia de Lange syndrome: first international consensus statement

  • Kline, A.D.
  • Moss, J.F.
  • Selicorni, A.
  • Bisgaard, A.M.
  • Deardorff, M.A.
  • Gillett, P.M.
  • Ishman, S.L.
  • Kerr, L.M.
  • Levin, A.V.
  • Mulder, P.A.
  • Ramos, F.J.
  • Wierzba, Jl
  • Ajmone, P.F.
  • Axtell, D.
  • Blagowidow, N.
  • Cereda, A.
  • Costantino, A.
  • Cormier-Daire, V.
  • FitzPatrick, D.
  • Grados, M.
  • Groves, L.
  • Guthrie, W.
  • Huisman, S.
  • Kaiser, F.J.
  • Koekkoek, G.
  • Levis, M.
  • Mariani, M.
  • McCleery, J.P.
  • Menke, L.A.
  • Metrena, A
  • O'Connor, J.
  • Oliver, C.
  • Pie, J.
  • Piening, S.
  • Potter, C.J.
  • Quaglio, A.L.
  • Redeker, E.
  • Richman, D.
  • Rigamonti, C.
  • Shi, A.
  • Tümer, Z.
  • Van Balkom, I.D.C.
  • Hennekam, R.C.
Cornelia de Lange syndrome (CdLS) is an archetypical genetic syndrome that is characterized by intellectual disability, well-defined facial features, upper limb anomalies and atypical growth, among numerous other signs and symptoms. It is caused by variants in any one of seven genes, all of which have a structural or regulatory function in the cohesin complex. Although recent advances in next-generation sequencing have improved molecular diagnostics, marked heterogeneity exists in clinical and molecular diagnostic approaches and care practices worldwide. Here, we outline a series of recommendations that document the consensus of a group of international experts on clinical diagnostic criteria, both for classic CdLS and non-classic CdLS phenotypes, molecular investigations, long-term management and care planning.